Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal ozone therapy in hospitalized patients with mild-moderate COVID-19
2021-002744-74Phase 3Active
- Sponsor
- Sociedad Española de Ozonoterapia
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in coronavirus disease 2019 (COVID-19) comparing Rectal ozone therapy with Control/placebo (2 arms). Primary endpoint: SaO2/FiO2 ratio. Started May 2021; status: active.
02
Drugs
medical ozonated water
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-002744-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002744-74.